The expression of NF-κB, Ki-67 and MMP-9 in CCOT, DGCT and GCOC

Oral Oncology

Volumn 45, Issue 6, 2009, Pages 515-520

  Gong, Yanling ^a,b   Wang, Li ^a,c   Wang, Hengkun ^d   Li, Tiejun ^e   Chen, Xinming ^a,c  

^a BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

^b The Second Hospital of Weihai   (China)

^c WUHAN UNIVERSITY   (China)

^d Weihai Municipal Hospital   (China)

^e PEKING UNIVERSITY   (China)

Author keywords

Calcifying cystic odontogenic tumor (CCOT); Calcifying odontogenic cyst; Dentinogenic ghost cell tumor (DGCT); Ghost cell odontogenic carcinoma (GCOC); Matrix metalloproteinase; Nuclear factor B; Proliferation

Indexed keywords

GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KI 67 ANTIGEN; TUMOR PROTEIN;

AMELOBLASTOMA; ARTICLE; CALCIFYING CYSTIC ODONTOGENIC TUMOR; CLINICAL ARTICLE; CONTROLLED STUDY; DENTINOGENIC GHOST CELL TUMOR; GHOST CELL ODONTOGENIC CARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ODONTOGENIC TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR CELL; CHINA; IN SITU HYBRIDIZATION; JAW TUMOR; METABOLISM; METHODOLOGY; ODONTOGENIC CYST;

AMELOBLASTOMA; CHINA; HUMANS; IN SITU HYBRIDIZATION; JAW NEOPLASMS; KI-67 ANTIGEN; MATRIX METALLOPROTEINASE 9; NEOPLASM PROTEINS; NF-KAPPA B; ODONTOGENIC CYST, CALCIFYING; ODONTOGENIC TUMORS;

EID: 67349174200     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2008.07.004     Document Type: Article

References (26)

1. Gorlin R.J., Pindborg J.J., and Clausen F.P. The calcifying odontogenic cyst: a possible analogue of the cutaneous calcifying epithelioma of Malherbe. An analysis of fifteen cases. Oral Surg Oral Med Oral Pathol 15 (1962) 1235-1243
2. Pindborg J.J., Kramer I.R.H., and Torloni H. Calcifying odontogenic cyst. Histological typing of odontogenic tumors, jaw cysts and allied lesions. WHO International Histological Classification of Tumors (1971), World Health Organization, Geneva p. 28
3. Kramer I.R.H., Pindborg J.J., and Shear M. Histological typing of odontogenic tumors. WHO international histological classification of tumors. 2nd ed. (1992), Springer Verlag, Berlin 20-21
4. Prætorius F., and Ledesma-Montes C. Calcifying cystic odontogenic tumor and Dentinogenic ghost cell tumor. In: Barnes L., Eveson J.W., and Reichar P. (Eds). Pathology and genetics of head and neck tumors (2005), IARC Press, Lyon, France 313-314
5. Rayet B., and Gelinas C. Aberrant rel/NF-κB genes and activity in human cancer. Oncogene 18 49 (1999) 6938-6947
6. Yamanaka N., Morisaki T., Nakashima H., et al. Interleukin 1beta enhances invasive ability of gastric carcinoma through nuclear factor-kappa B activation. Clin Cancer Res 10 5 (2004) 1853-1859
7. Shukla S., MacLennan G.T., and Fu P. Nuclear factor-kappaB/p65 (Rel A) is constitutively activated in human prostate adenocarcinoma and correlates with disease progression. Neoplasia 6 4 (2004) 390-400
8. Helbig G., Christopherson K.W., and Bhat-Nakshatri P. NF-κB promotes breast cancer cell migration and metastasis by inducing the expression of the chemokine receptor CXCR4. J Biol Chem 278 (2003) 21631-21638
9. Zhang J.L., Peng B., and Chen X.M. Expression of nuclear factor κB, inducible nitric oxide sunthase, and vascular endothelial growth factor in adenoid cystic carcinoma of salivary and clinical outcome. Clin Cancer Res 11 20 (2005) 7334-7343
10. Kumamoto H., and Ooya K. Expression of tumor necrosis factor α, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. J Oral Pahol Med 34 (2005) 287-294
11. Pinheiro J.J., Freitas V.M., and Moretti A.I. Local invasiveness of ameloblastoma. Role played by matrix metalloproteinases and proliferative activity. Histopathology 45 1 (2004) 65-72
12. Kumamoto H., Yamauchi K., and Yoshida M. Immunohistochemical detection of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in ameloblastomas. J Oral Pathol Med 32 2 (2003) 114-120
13. Meer S., Galpin J.S., and Altini M. Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95 2 (2003) 213-221
14. Brown D.C., and Gatter K.C. Ki67 protein: the immaculate deception?. Histopathology 40 1 (2002) 2-11
15. Bhuvarahamurthy V., Kristiansen Glen O., Johannsen M., et al. In situ gene expression and localization of metalloproteinases MMP1, MMP2, MMP3, MMP9, and their inhibitors TIMP1 and TIMP2 in human renal cell carcinoma. Oncol Rep 15 (2006) 1379-1384
16. Nakayama H., Ikebe T., Beppu M., and Shirasuna K. High expression levels of nuclear factor κB, IκB, kinase a and Akt kinase in squamous cell carcinoma of the oral cavity. Cancer 92 (2001) 3037-3044
17. Kadowaki T., Shiozaki H., and Inoue M. E-cadherin and α-catenin expression in human esophageal cancer. Cancer Res 54 1 (1994) 291-296
18. Todia M. So-called calcifying odontogenic cyst: review and discussion on the terminology and classification. J Oral Pathol Med 27 (1998) 49-52
19. Li T.-J., and Yu S.-F. Clinicopathologic spectrum of the so-called calcifying odontogenic cysts: a study of the terminology and classification. Am J Surg Pathol 27 (2003) 372-384
20. Hidalgo M., and Eckhardt S.G. Development of matrix metalloproteinase inhibitors in cancer therapy. J Nat Cancer Inst 93 3 (2001) 178-193
21. Monteagudo C., Merino M.J., and San-Juan J. Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. Am J Pathol 136 (1990) 585-592
22. Maatta M., Soini Y., Liakka A., and Autio-Harmainen H. Differential expression of matrix metalloproteinase (MMP) -2, MMP-9, and membrane type 1-MMP in hepatocellular and pancreatic adenocarcinoma: implications for tumor progression and clinical prognosis. Clin Cancer Res 6 (2000) 2726-2734
23. Canete-Soler R., Litzky L., Lubensky I., and Muschel R.J. Localization of the 92 kd gelatinase mRNA in squamous cell and adenocarcinomas of the lung using in situ hybridization. Am J Pathol 144 (1994) 518-527
24. Chantrain C.F., Shimada H., and Jodele S. Stromal matrix metalloproteinase-9 regulates the vascular architecture in neuroblastoma by promoting pericyte recruitment. Cancer Res 64 5 (2004) 1675-1686
25. Himelstein B.P., Canete-Soler R., and Bernhard E.J. Metalloproteinases in tumor progression: the contribution of MMP-9. Invas Metastasis 14 (1994) 246-258
26. Polette M., Nawrocki-Raby B., and Gilles C. Tumor invasion and matrix metalloproteinases. Crit Rev Oncol Hematol 49 3 (2004) 179-186